AJP - Cell Physiology, Vol 264, Issue 2 C479-C484, Copyright © 1993 by American Physiological Society

ARTICLES

ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats

V. K. Batra, J. R. McNeill, Y. Xu, T. W. Wilson and V. Gopalakrishnan
Department of Pharmacology, University of Saskatchewan, Saskatoon, Canada.

The effect of the agonist sarafotoxin 6c (S6c), selective for endothelin (ET) receptor subtype B (ETB), on cytosolic free Ca2+ concentrations ([Ca2+]i) was determined by fura-2 methodology using aortic smooth muscle cells (ASMC) isolated from spontaneously hypertensive rats (SHR) and two normotensive strains, Wistar-Kyoto (WKY) and Sprague-Dawley (SD) rats. The basal [Ca2+]i was significantly higher in the ASMC of SHR (139 +/- 8 nM) than WKY (107 +/- 7 nM) and SD (102 +/- 4 nM) rats. S6c produced concentration-dependent elevations in [Ca2+]i in the ASMC of WKY and SHR, whereas it did not evoke significant increases in the [Ca2+]i levels in the ASMC of SD rats. The peak [Ca2+]i levels observed with maximal concentrations of S6c (500 nM) was higher (P < 0.01) in the SHR (346 +/- 36 nM) than the WKY group (148 +/- 19 nM). The natural nonselective agonist, ET-1, evoked maximal [Ca2+]i in the ASMC of SHR, WKY, and SD rats of 635 +/- 43, 304 +/- 19, and 289 +/- 24 nM, respectively. Depletion of extracellular Ca2+ concentration led to the reduction of the peak [Ca2+]i response to ET-1 by 60 and 40% in the WKY and SHR cells, respectively, whereas the response to S6c remained unaffected. The ETA-selective antagonist, BQ-123 (1 microM), did not affect the [Ca2+]i response to S6c, whereas it attenuated the response to ET-1 by 90 and 70% in the WKY and SHR cells, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				Y. Kawanabe, Y. Okamoto, T. Enoki, N. Hashimoto, and T. Masaki Ca2+ channels activated by endothelin-1 in CHO cells expressing endothelin-A or endothelin-B receptors Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1676 - C1685. [Abstract] [Full Text] [PDF]

				S. M. Balakrishnan, H. D. Wang, V. Gopalakrishnan, T. W. Wilson, and J. R. McNeill Effect of an Endothelin Antagonist on Hemodynamic Responses to Angiotensin II Hypertension, November 1, 1996; 28(5): 806 - 809. [Abstract] [Full Text]

				R. M. Touyz, L. Y. Deng, and E. L. Schiffrin Endothelin Subtype B Receptor–Mediated Calcium and Contractile Responses in Small Arteries of Hypertensive Rats Hypertension, December 1, 1995; 26(6): 1041 - 1045. [Abstract] [Full Text]

				E. L. Schiffrin Endothelin: Potential Role in Hypertension and Vascular Hypertrophy Hypertension, June 1, 1995; 25(6): 1135 - 1143. [Abstract] [Full Text]

				T. Kitazono, D. D. Heistad, and F. M. Faraci Enhanced Responses of the Basilar Artery to Activation of Endothelin-B Receptors in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, April 1, 1995; 25(4): 490 - 494. [Abstract] [Full Text]

				J.-S. Li and E. L. Schiffrin Effect of Chronic Treatment of Adult Spontaneously Hypertensive Rats With an Endothelin Receptor Antagonist Hypertension, April 1, 1995; 25(4): 495 - 500. [Abstract] [Full Text]

				B. Seo and T. F. Luscher ETA and ETB Receptors Mediate Contraction to Endothelin-1 in Renal Artery of Aging SHR : Effects of FR139317 and Bosentan Hypertension, April 1, 1995; 25(4): 501 - 506. [Abstract] [Full Text]

				H. Takase, P. Moreau, and T. F. Luscher Endothelin Receptor Subtypes in Small Arteries : Studies With FR139317 and Bosentan Hypertension, April 1, 1995; 25(4): 739 - 743. [Abstract] [Full Text]